Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2003 Feb;56(1):1-10.
doi: 10.1136/mp.56.1.1.

Molecular aspects of type 1 diabetes

Affiliations
Review

Molecular aspects of type 1 diabetes

M A Kelly et al. Mol Pathol. 2003 Feb.

Abstract

Type 1 diabetes is a T cell mediated autoimmune disease, characterised by the selective destruction of pancreatic beta cells, and susceptibility is determined by a combination of genetic and environmental factors. The environmental agents implicated include viruses and dietary factors, although none has yet been shown to be directly responsible for triggering beta cell autoimmunity. The genetic factors that influence disease risk have been subjected to more intensive study and two gene regions of major importance have been identified: the human leucocyte antigen locus and the insulin gene. This review will focus on the mechanisms by which these genes might influence the risk of developing type 1 diabetes.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A simplified map of the major histocompatibility complex on chromosome 6p21, showing the genes arranged in three classes. Hsp, heat shock protein; TNF, tumour necrosis factor.
Figure 2
Figure 2
A diagrammatic representation of (A) a human leucocyte antigen (HLA) class I molecule and (B) an HLA class II molecule, showing the antigen binding clefts.
Figure 3
Figure 3
Antigen presentation to the T cell receptor of a CD4 positive helper T cell by a human leucocyte antigen class II molecule.
Figure 4
Figure 4
The antigen binding cleft of a human leucocyte antigen class II molecule showing the binding pockets (P1, P4, and P9) and the amino acid residues implicated in peptide binding and T cell activation.
Figure 5
Figure 5
The antigen binding cleft of a human leucocyte antigen class II DQ molecule, showing the salt bridge between residues β57 and α79.

References

    1. Couper JJ, Hudson I, Werther GA, et al. Factors predicting residual beta-cell function in the first year after diagnosis of childhood type 1 diabetes. Diabetes Res Clin Pract 1991;11:9–16. - PubMed
    1. Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes. Diabetes 1965;14:619–33. - PubMed
    1. Gepts W, De Mey J. Islet cell survival determined by morphology: an immunocytochemical study of the islets of Langerhans in juvenile diabetes mellitus. Diabetes 1978;27:251–61. - PubMed
    1. MacCuish AC, Jordan J, Campbell CJ, et al. Cell mediated immunity in diabetes mellitus: lymphocyte transformation by insulin and insulin fragments in insulin treated and newly diagnosed diabetics. Diabetes 1975;24:36–43. - PubMed
    1. Naquet P, Ellis J, Tibensky D, et al. T cell autoreactivity to insulin in diabetic and related non-diabetic individuals. J Immunol 1988;140:2569–78. - PubMed

MeSH terms